explore -WSS

explore

author：focus 2025-09-29 12:30:03 - browse：32

James Comer (R-KY) walks on the House side of the U.S. Capitol on May 14, 2024 in Washington, DC — Rep. James Comer (R-Ky.), the chair of the House Committee on Oversight and Accountability, has taken an interest in pharmacy benefit managers. Kent Nishimura/Getty Images

WASHINGTON — Executives from the three major pharmacy benefit manager companies have been invited to testify before the House Committee on Oversight and Accountability next month, four sources familiar with the planning told STAT.

Executives from Optum, CVS Caremark, and Express Scripts, owned by Cigna, were asked to testify before the panel on June 4.

The committee and companies did not respond to requests for comment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

explore

entertainment

WSS

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

ASCO Takeaways: Winners, snoozers, and the art of cancer care

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Illumina board agrees to spin off Grail, as divestment plans proceed

Finland to offer bird flu vaccine to select groups of people, a possible global first

STAT wants to know your pick for a great summer read or listen

leisure time

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

BioMarin wins approval for gene therapy to treat hemophilia A

Congress needs to close a vaccine

In Memoriam: Notable people who died in 2023

Arc Institute generative AI designs new CRISPR systems

Virginia high school admissions case could be legal follow

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Bright Health sells Medicare Advantage business to Molina

Wearables generate powerful data but its not useful to doctors, yet

Wildfire smoke exposes gaps in outdoor worker protections

Eli Lilly’s Zepbound improved liver scarring in mid

Wikipedia

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Sutter Health’s antitrust win overturned by appeals court

Readers respond to H5N1 and livestock movements, and more

Elevance PBM president out as customers face prescription chaos

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

knowledge

explore

entertainment

hotspot